Resolute Oncology Inc (REON) SEC Filing 8-K Material Event for the period ending Monday, February 4, 2013

Resolute Oncology Inc

CIK: 1470022 Ticker: REON

View differences made from one to another to evaluate Resolute Oncology Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Resolute Oncology Inc.


Assess how Resolute Oncology Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Resolute Oncology Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: REON
CIK: 1470022
Form Type: 8-K Corporate News
Accession Number: 0001038838-13-000036
Submitted to the SEC: Thu Feb 07 2013 3:47:45 PM EST
Accepted by the SEC: Thu Feb 07 2013
Period: Monday, February 4, 2013
Industry: Metal Mining
  1. Unregistered Sales

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: